After the DM group was treated with nanoparticle-encapsulated curcumin, the relative levels of the P2Y12 mRNA were significantly decreased compared to those in the untreated DM group (p < 0.01; Figure 2A). The gene discussed is P2RY12; the disease is diabetes mellitus.